IBBvsSPDW
iShares Biotechnology ETF against SPDR Portfolio Developed World ex-US ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBB | SPDW | |
|---|---|---|
| Expense ratio | 0.45% | 0.030% |
| Assets | $10.6B | $41B |
| Net flow, 1 month | +$124M | — |
| Net flow, 1 year | +$1.8B | +$4.9B |
| Return, YTD | +20.3% | +13.8% |
| Return, 1 year | +34.9% | +15.7% |
| Avg daily volume | 1.6M | 2.6M |
| Holdings | 221 | 2480 |
| Listed | Feb 5, 2001 | Apr 20, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS